Leuprolide Acetate Kit
Product Images NDC 72843-591

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 72843-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ubi Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Figurea)

An instructional line drawing illustrating a hand holding a syringe, likely showing the technique to prepare or administer a subcutaneous injection. The syringe is partially filled, with the plunger being pressed by the thumb and forefinger stabilizing the barrel.*

FDA Label Image

Figure B (Figureb)

An instructional black-and-white illustration showing hands being washed under a running faucet. Water flows over the hands, emphasizing cleansing. This image is likely demonstrating proper handwashing technique.*

FDA Label Image

Figure C (Figurec)

Black-and-white instructional illustration showing a finger removing the cap from a vial, likely representing preparation for subcutaneous injection. The image appears related to the leuprolide acetate kit for subcutaneous use.*

FDA Label Image

Figure D (Figured)

An instructional illustration showing fingers holding a small component, likely part of a subcutaneous injection kit for leuprolide acetate. The image highlights detailed handling of a device or vial cap, demonstrating a step in preparation or administration of the medication.*

FDA Label Image

Figure E (Figuree)

An instructional black-and-white illustration showing a hand holding a syringe. The syringe is being prepared with the plunger partially withdrawn, indicated by a rightward arrow, likely demonstrating how to draw or expel fluid from the syringe.*

FDA Label Image

Figure F (Figuref)

An instructional illustration showing a hand holding a syringe used for subcutaneous injection preparation. The image displays a close-up of the injection device and needle tip, demonstrating how to properly hold the components before administration.*

FDA Label Image

Figure G (Figureg)

An instructional illustration showing a person's hands manipulating a syringe or vial, likely demonstrating preparation or reconstitution of a subcutaneous injection associated with leuprolide acetate kit from UBI Pharma Inc.*

FDA Label Image

Figure H (Figureh)

An illustration showing a close-up of a hand holding a vial or syringe. The image focuses on the fingers grasping the device, suggesting preparation or administration of a subcutaneous injection, consistent with the leuprolide acetate kit.*

FDA Label Image

Figure I (Figurei)

An instructional illustration showing two hands drawing liquid from a vial into a syringe. The image demonstrates the technique of inverting the vial and pulling the syringe plunger to fill the syringe with medication.*

FDA Label Image

Figure J (Figurej)

An instructional line drawing shows a hand injecting a medication subcutaneously into the forearm of another hand, demonstrating the technique for using the leuprolide acetate subcutaneous injection kit by UBI Pharma Inc.*

FDA Label Image

Figure K (Figurek)

An instructional illustration showing a person administering a subcutaneous injection. One hand holds a syringe inserted at a 90-degree angle into the skin, while the other hand presses a pad or cotton ball on the injection site to possibly stabilize or clean the area.*

FDA Label Image

Figure L (Figurel)

A black and white illustration showing a hand disposing of a syringe into a sharps container with a circular opening on top. The container has a label on the front side. This image likely relates to safe disposal practices for subcutaneous injection kits like leuprolide acetate.*

FDA Label Image

Leuprolide Acetate Injection Carton (Leuprolide Carton)

Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) sterile kit for subcutaneous injection. The multi-dose vial is labeled for prescription use by UBI Pharma Inc. The carton includes dosing instructions and storage information, with a barcode and manufacturer details from Taiwan.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of leuprolide acetate illustrating the molecular arrangement of atoms and bonds in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.